ArticleBMC cancer2019

PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.

Xiaoli Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.